The primary importance of environmental monitoring for Advanced Therapeutic Medicinal Products (ATMP) facilities is to demonstrate the highest degree of control over
* The aseptic manufacturing environment
* The potential for cross contamination between batches / manipulations
Read this paper for an easy-to-understand explanation of the meaning of the newest EU GMP Annex 1 2022. The charts provide a section-by-section practical explanation and interpretation of Annex 1.
Continuous monitoring helps ensure the sterility of clean manufacturing within the pharmaceutical industry. In the pharmaceutical field, one of the main objectives required by regulatory guidelines is to preserve the sterility of cleanrooms. Cleanrooms are controlled areas where contamination levels are monitored and managed to meet a defined cleanliness level. To reach this goal, it is important to ensure that each GMP requirement is respected over time.
In discussing acceptable particle losses in tubing, there are many factors. Transportation of particles in tubing between a sample inlet and the optics of particle counters has at many times been at the forefront of discussion regarding the truth of readings. When the validation implications of losses due to various forces are reviewed, the certainty of the result is always in question. So, what are these forces, what are the losses, and what are the acceptable results? This paper addresses these issues to allow for a better understanding of the problem.